Search - tctmd.com

Displaying 381 - 400 of 413

Sort: Relevancy | Date

News Daily News

AIDA STEMI Substudy Confirms No Advantage for Intracoronary Abciximab

February 27, 2013

News Daily News

Streamlined STEMI Guidelines Aim to Be Clinician-Friendly

December 19, 2012

News Daily News

Los Alelos Genéticos Influyen en la Respuesta al Prasugrel de los Pacientes víctimas de un SCA

Jason Kahn

December 17, 2012

News Daily News

Genetic Alleles Affect Response to Prasugrel in ACS Patients

Jason Kahn

December 17, 2012

News Daily News

Los Índices de PCI para los IAM son Más Bajos en aquellos Estados que Facilitan Información

Yael L. Maxwell

October 10, 2012

News Daily News

Danish Study Looks at Impact of Socioeconomic Status on Primary PCI Outcomes

Caitlin E. Cox

October 09, 2012

News Daily News

Thrombus Aspiration Improves Clinical Outcomes in STEMI Patients

L.A. McKeown

September 26, 2012

News Daily News

Early Aggressive Strategy in Elderly NSTE ACS Patients Not Harmful, Advantage Still Elusive

Caitlin E. Cox

September 20, 2012

News Daily News

Timing of Platelet Testing Key to Optimal Therapy After PCI for ACS

L.A. McKeown

August 20, 2012

News Daily News

La programación de pruebas de plaqueta es fundamental para la estrategia de clopidogrel después de una ICP por ACS

L.A. McKeown

August 20, 2012

News Daily News

Sigue habiendo Problemas para Acortar los Tiempos de Reperfusión en Pacientes STEMI Trasladados

Yael L. Maxwell

August 15, 2012

News Daily News

Hurdles Remain in Shortening Reperfusion Times for Transferred STEMI Patients

Yael L. Maxwell

August 15, 2012

News Daily News

Un Meta Análisis Favorece el Abciximab Intracoronario frente al Abciximab Intravenoso en PCI Primarias

June 05, 2012

News Daily News

Meta-analysis Favors Intracoronary vs. Intravenous Abciximab in Primary PCI

June 05, 2012

News Daily News

Subestudio PLATO: Los Pacientes con SCA y Antecedentes de ACV no están en Desventaja con el Ticagrelor

Yael L. Maxwell

June 01, 2012

News Daily News

PLATO Substudy: ACS Patients with Prior Stroke at No Disadvantage with Ticagrelor

Yael L. Maxwell

June 01, 2012

News Conference News ACC 2012

INFUSE-AMI: Bolus Abciximab Works, Thrombus Aspiration Doesn’t for Large STEMI

Jason Kahn

March 25, 2012

News Daily News

Timely PCI Access Not Improved by Increase in PCI-Capable Hospitals

Leah Lawrence

March 06, 2012

News Daily News

Medidas Drásticas para Acortan el Tiempo de Derivación a una PCI Primaria

March 06, 2012

News Conference News

AIDA STEMI: No Advantage for Intracoronary vs. Intravenous Abciximab

November 13, 2011

Advertisement

AIDA STEMI Substudy Confirms No Advantage for Intracoronary Abciximab

Streamlined STEMI Guidelines Aim to Be Clinician-Friendly

Los Alelos Genéticos Influyen en la Respuesta al Prasugrel de los Pacientes víctimas de un SCA

Genetic Alleles Affect Response to Prasugrel in ACS Patients

Los Índices de PCI para los IAM son Más Bajos en aquellos Estados que Facilitan Información

Danish Study Looks at Impact of Socioeconomic Status on Primary PCI Outcomes

Thrombus Aspiration Improves Clinical Outcomes in STEMI Patients

Early Aggressive Strategy in Elderly NSTE ACS Patients Not Harmful, Advantage Still Elusive

Timing of Platelet Testing Key to Optimal Therapy After PCI for ACS

La programación de pruebas de plaqueta es fundamental para la estrategia de clopidogrel después de una ICP por ACS

Sigue habiendo Problemas para Acortar los Tiempos de Reperfusión en Pacientes STEMI Trasladados

Hurdles Remain in Shortening Reperfusion Times for Transferred STEMI Patients

Un Meta Análisis Favorece el Abciximab Intracoronario frente al Abciximab Intravenoso en PCI Primarias

Meta-analysis Favors Intracoronary vs. Intravenous Abciximab in Primary PCI

Subestudio PLATO: Los Pacientes con SCA y Antecedentes de ACV no están en Desventaja con el Ticagrelor

PLATO Substudy: ACS Patients with Prior Stroke at No Disadvantage with Ticagrelor

INFUSE-AMI: Bolus Abciximab Works, Thrombus Aspiration Doesn’t for Large STEMI

Timely PCI Access Not Improved by Increase in PCI-Capable Hospitals

Medidas Drásticas para Acortan el Tiempo de Derivación a una PCI Primaria

AIDA STEMI: No Advantage for Intracoronary vs. Intravenous Abciximab

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content